Encorafenib (LGX818)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 23:45, 27 June 2018 by Jwarner (talk | contribs) (Jwarner moved page Encorafenib (LGX818) to Encorafenib (Braftovi): FDA approval)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Redirect page
Jump to navigation Jump to search

Redirect to:

Retrieved from "https://hemonc.org/w/index.php?title=Encorafenib_(LGX818)&oldid=28289"